共 82 条
[11]
Sanchez E(2017)Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology Semin Immunopathol 395 529-ee6
[12]
Tattersall RS(2020)Cytokine release syndrome in severe COVID-19 Science 3686490 473-481
[13]
Manson JJ(2020)Reducing mortality from 2019-nCoV: host-directed therapies should be an option Lancet 39510224 e35-492
[14]
Xu X(2020)Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Lancet Respir Med 85 475-239
[15]
Han M(2020)Predictive factors for disease progression in hospitalized patients with coronavirus disease 2019 in Wuhan, China J Clin Virol 127 104392-929
[16]
Li T(2014)Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, phase-III study J Am Acad Dermatol 713 484-ee8
[17]
Sun W(2018)The anti-CD6 antibody itolizumab provides clinical benefit without lymphopenia in rheumatoid arthritis patients: results from a 6-month, open-label phase I clinical trial Clin Exp Immunol 1912 229-undefined
[18]
Wang D(2020)COVID-19 and older adults: what we know J Am Geriatr Soc 685 926-undefined
[19]
Fu B(2020)Clinical features of COVID-19 in elderly patients: a comparison with young and middle-aged patients J Inf Secur 806 e14-undefined
[20]
Dogra S(undefined)undefined undefined undefined undefined-undefined